カテゴリー： GlobalInfoResearch, 世界

季節性情動障害治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Seasonal Affective Disorder Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9101311）・商品コード：GIR9101311
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月10日（※2024年版があります。お問い合わせください）
・ページ数：119
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、季節性情動障害治療薬の世界市場について調べ、まとめました。種類別セグメントは、光療法（光線療法）、薬物療法、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。季節性情動障害治療薬の世界市場概観、企業動向、企業別季節性情動障害治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・季節性情動障害治療薬の市場概観
・季節性情動障害治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・季節性情動障害治療薬の企業別販売動向、市場シェア、市場集中度、競争動向
・季節性情動障害治療薬の世界市場規模
・季節性情動障害治療薬の北米市場分析（アメリカ、カナダ、メキシコ等）
・季節性情動障害治療薬のアメリカ市場規模推移
・季節性情動障害治療薬のカナダ市場規模推移
・季節性情動障害治療薬のメキシコ市場規模推移
・季節性情動障害治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・季節性情動障害治療薬のドイツ市場規模推移
・季節性情動障害治療薬のイギリス市場規模推移
・季節性情動障害治療薬のロシア市場規模推移
・季節性情動障害治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・季節性情動障害治療薬の日本市場規模推移
・季節性情動障害治療薬の中国市場規模推移
・季節性情動障害治療薬の韓国市場規模推移
・季節性情動障害治療薬のインド市場規模推移
・季節性情動障害治療薬の東南アジア市場規模推移
・季節性情動障害治療薬の南米市場分析（ブラジル、アルゼンチン等）
・季節性情動障害治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・季節性情動障害治療薬の種類別分析/販売量、売上、市場シェア（光療法（光線療法）、薬物療法、その他）
・季節性情動障害治療薬の用途別分析/市場規模（病院、診療所、その他）
・季節性情動障害治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・季節性情動障害治療薬の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety.

Scope of the Report:
The global Seasonal Affective Disorder Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Seasonal Affective Disorder Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Seasonal Affective Disorder Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Seasonal Affective Disorder Therapeutics market by product type and applications/end industries.

Market Segment by Companies, this report covers
Allergan
Pfizer
Roche
Eli Lily
GlaxoSmithKline
Teva Pharmaceuticals
Bausch Health Companies
Mylan
Sanofi
Novartis
Johnson & Johnson
Koninklijke Philips
Beurer GmbH
Lucimed (Luminette)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Light Therapy (Phototherapy)
Medication
Others

Market Segment by Applications, can be divided into
Hospitals
Clinics
Others

【レポートの目次】

Table of Contents

1 Seasonal Affective Disorder Therapeutics Market Overview
1.1 Product Overview and Scope of Seasonal Affective Disorder Therapeutics
1.2 Classification of Seasonal Affective Disorder Therapeutics by Types
1.2.1 Global Seasonal Affective Disorder Therapeutics Revenue Comparison by Types (2019-2024)
1.2.2 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Types in 2018
1.2.3 Light Therapy (Phototherapy)
1.2.4 Medication
1.2.5 Others
1.3 Global Seasonal Affective Disorder Therapeutics Market by Application
1.3.1 Global Seasonal Affective Disorder Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Seasonal Affective Disorder Therapeutics Market by Regions
1.4.1 Global Seasonal Affective Disorder Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Seasonal Affective Disorder Therapeutics Status and Prospect (2014-2024)
1.5 Global Market Size of Seasonal Affective Disorder Therapeutics (2014-2024)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.3 Roche
2.3.1 Business Overview
2.3.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.4 Eli Lily
2.4.1 Business Overview
2.4.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.5 GlaxoSmithKline
2.5.1 Business Overview
2.5.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.6 Teva Pharmaceuticals
2.6.1 Business Overview
2.6.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.7 Bausch Health Companies
2.7.1 Business Overview
2.7.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.8 Mylan
2.8.1 Business Overview
2.8.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.10 Novartis
2.10.1 Business Overview
2.10.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.11 Johnson & Johnson
2.11.1 Business Overview
2.11.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.12 Koninklijke Philips
2.12.1 Business Overview
2.12.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.13 Beurer GmbH
2.13.1 Business Overview
2.13.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
2.14 Lucimed (Luminette)
2.14.1 Business Overview
2.14.2 Seasonal Affective Disorder Therapeutics Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Seasonal Affective Disorder Therapeutics Market Competition, by Players
3.1 Global Seasonal Affective Disorder Therapeutics Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Seasonal Affective Disorder Therapeutics Players Market Share
3.2.2 Top 10 Seasonal Affective Disorder Therapeutics Players Market Share
3.3 Market Competition Trend
4 Global Seasonal Affective Disorder Therapeutics Market Size by Regions
4.1 Global Seasonal Affective Disorder Therapeutics Revenue and Market Share by Regions
4.2 North America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.3 Europe Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.5 South America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Seasonal Affective Disorder Therapeutics Revenue by Countries
5.1 North America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
5.2 USA Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5.3 Canada Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
5.4 Mexico Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Seasonal Affective Disorder Therapeutics Revenue by Countries
6.1 Europe Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
6.2 Germany Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.3 UK Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.4 France Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.5 Russia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
6.6 Italy Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue by Countries
7.1 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
7.2 China Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.3 Japan Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.4 Korea Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.5 India Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Seasonal Affective Disorder Therapeutics Revenue by Countries
8.1 South America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
8.2 Brazil Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8.3 Argentina Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
8.4 Colombia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Seasonal Affective Disorder Therapeutics by Countries
9.1 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
9.2 Saudi Arabia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.3 UAE Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.4 Egypt Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.5 Nigeria Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
9.6 South Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Seasonal Affective Disorder Therapeutics Market Segment by Type
10.1 Global Seasonal Affective Disorder Therapeutics Revenue and Market Share by Type (2014-2019)
10.2 Global Seasonal Affective Disorder Therapeutics Market Forecast by Type (2019-2024)
10.3 Light Therapy (Phototherapy) Revenue Growth Rate (2014-2024)
10.4 Medication Revenue Growth Rate (2014-2024)
10.5 Others Revenue Growth Rate (2014-2024)
11 Global Seasonal Affective Disorder Therapeutics Market Segment by Application
11.1 Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Application (2014-2019)
11.2 Seasonal Affective Disorder Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Seasonal Affective Disorder Therapeutics Market Size Forecast (2019-2024)
12.1 Global Seasonal Affective Disorder Therapeutics Market Size Forecast (2019-2024)
12.2 Global Seasonal Affective Disorder Therapeutics Market Forecast by Regions (2019-2024)
12.3 North America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.4 Europe Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.6 South America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Seasonal Affective Disorder Therapeutics Picture
Table Product Specifications of Seasonal Affective Disorder Therapeutics
Table Global Seasonal Affective Disorder Therapeutics and Revenue (Million USD) Market Split by Product Type
Figure Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Types in 2018
Figure Light Therapy (Phototherapy) Picture
Figure Medication Picture
Figure Others Picture
Table Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Application (2014-2024)
Figure Seasonal Affective Disorder Therapeutics Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Seasonal Affective Disorder Therapeutics Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Seasonal Affective Disorder Therapeutics Type and Applications
Table Allergan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Seasonal Affective Disorder Therapeutics Type and Applications
Table Pfizer Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Seasonal Affective Disorder Therapeutics Type and Applications
Table Roche Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lily Basic Information, Manufacturing Base and Competitors
Table Eli Lily Seasonal Affective Disorder Therapeutics Type and Applications
Table Eli Lily Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Seasonal Affective Disorder Therapeutics Type and Applications
Table GlaxoSmithKline Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Type and Applications
Table Teva Pharmaceuticals Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Seasonal Affective Disorder Therapeutics Type and Applications
Table Bausch Health Companies Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Seasonal Affective Disorder Therapeutics Type and Applications
Table Mylan Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Seasonal Affective Disorder Therapeutics Type and Applications
Table Sanofi Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Seasonal Affective Disorder Therapeutics Type and Applications
Table Novartis Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Seasonal Affective Disorder Therapeutics Type and Applications
Table Johnson & Johnson Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Koninklijke Philips Basic Information, Manufacturing Base and Competitors
Table Koninklijke Philips Seasonal Affective Disorder Therapeutics Type and Applications
Table Koninklijke Philips Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Beurer GmbH Basic Information, Manufacturing Base and Competitors
Table Beurer GmbH Seasonal Affective Disorder Therapeutics Type and Applications
Table Beurer GmbH Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Lucimed (Luminette) Basic Information, Manufacturing Base and Competitors
Table Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Type and Applications
Table Lucimed (Luminette) Seasonal Affective Disorder Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
Table Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Players (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue Share by Players (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Players in 2017
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Players in 2018
Figure Global Top 5 Players Seasonal Affective Disorder Therapeutics Revenue Market Share in 2018
Figure Global Top 10 Players Seasonal Affective Disorder Therapeutics Revenue Market Share in 2018
Figure Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Regions (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Regions (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Market Share by Regions in 2018
Figure North America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Europe Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure South America Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table North America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
Table North America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure North America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure USA Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Canada Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Mexico Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Europe Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Europe Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Europe Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Germany Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure UK Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure France Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Russia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Italy Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure China Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Japan Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Korea Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure India Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table South America Seasonal Affective Disorder Therapeutics Revenue by Countries (2014-2019)
Table South America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure South America Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Brazil Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Argentina Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Colombia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Share by Countries in 2018
Figure Saudi Arabia Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure UAE Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Egypt Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure Nigeria Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Figure South Africa Seasonal Affective Disorder Therapeutics Revenue and Growth Rate (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) by Type (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue Share by Type (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Type (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Type in 2019
Table Global Seasonal Affective Disorder Therapeutics Revenue Forecast by Type (2019-2024)
Figure Global Seasonal Affective Disorder Therapeutics Market Share Forecast by Type (2019-2024)
Figure Global Light Therapy (Phototherapy) Revenue Growth Rate (2014-2019)
Figure Global Medication Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue by Application (2014-2019)
Table Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Application (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Share by Application in 2019
Table Global Seasonal Affective Disorder Therapeutics Revenue Forecast by Application (2019-2024)
Figure Global Seasonal Affective Disorder Therapeutics Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Seasonal Affective Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Seasonal Affective Disorder Therapeutics Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Europe Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure South America Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Seasonal Affective Disorder Therapeutics Revenue Market Forecast (2019-2024)


【掲載企業】

Allergan、Pfizer、Roche、Eli Lily、GlaxoSmithKline、Teva Pharmaceuticals、Bausch Health Companies、Mylan、Sanofi、Novartis、Johnson & Johnson、Koninklijke Philips、Beurer GmbH、Lucimed (Luminette)、

★調査レポート[季節性情動障害治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9101311)販売に関する免責事項を必ずご確認ください。
★調査レポート[季節性情動障害治療薬の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 甲状腺障害の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100330 / GlobalInfoResearch / 2019年10月11日 / 本調査レポートは、甲状腺障害の世界市場について調べ、まとめました。種類別セグメントは、甲状腺機能低下症、甲状腺機能亢進症等、用途別セグメントは、病院、診療所、その他等に区分しました。甲状腺障害の世界市場概観、企業動向、企業別甲状腺障害シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・甲状腺障害の市場概観 ・甲状腺障害の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・甲状腺障害の企業別販売動向、市場シェア、市場集中度、競争動向 ・甲状腺障害の世界市場規模 ・甲状腺障害の北米市場分析（アメリカ、カナダ、メキシコ等） ・甲状腺障害のアメリカ市場規模推移 ・甲状腺障害のカナダ市場規模推移 ・甲状腺障害のメキシコ市場規模推移 ・甲状腺障害のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The global Thyroid Disorder market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Thyroid Disorder. Europe also play important roles in global market,...
  • 睡眠障害治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101587 / GlobalInfoResearch / 2019年9月12日 / 本調査レポートは、睡眠障害治療の世界市場について調べ、まとめました。種類別セグメントは、不眠症、過度の睡眠、睡眠障害等、用途別セグメントは、病院薬局、オンライン薬局、小売薬局等に区分しました。睡眠障害治療の世界市場概観、企業動向、企業別睡眠障害治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・睡眠障害治療の市場概観 ・睡眠障害治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・睡眠障害治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・睡眠障害治療の世界市場規模 ・睡眠障害治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・睡眠障害治療のアメリカ市場規模推移 ・睡眠障害治療のカナダ市場規模推移 ・睡眠障害治療のメキシコ市場規模推移 ・睡眠障害治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime. Scope of the Report: The global Sleep Disorder Therapies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be...
  • 色素沈着低下障害治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101952 / GlobalInfoResearch / 2019年9月16日 / 本調査レポートは、色素沈着低下障害治療の世界市場について調べ、まとめました。種類別セグメントは、局所薬、レーザー、化学ピール、マイクロダーマブレーション、その他等、用途別セグメントは、病院、美容クリニック＆皮膚科センター、その他等に区分しました。色素沈着低下障害治療の世界市場概観、企業動向、企業別色素沈着低下障害治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・色素沈着低下障害治療の市場概観 ・色素沈着低下障害治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・色素沈着低下障害治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・色素沈着低下障害治療の世界市場規模 ・色素沈着低下障害治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・色素沈着低下障害治療のアメリカ市場規模推移 ・色素沈着低下障害治療のカナダ市場規模推移 ・色素沈着低下障害治療のメキシコ市場規模推移 ・色素沈着低下障害治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Hypopigmentation is characterized specifically as an area of skin becoming lighter than the baseline skin color, but not completely devoid of pigment. Scope of the Report: The global Hypopigmentation Disorder Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be...

    • ◆H&Iグローバルリサーチのお客様（例）◆